Abbott's New TactiFlex Ablation Catheter Revolutionizes Treatment for Abnormal Heart Rhythms

Monday, October 16, 2023

Abbott has announced the launch of its innovative TactiFlex™, Sensor Enabled™ ablation catheter, a pioneering advancement in the field of cardiac ablation technology. This catheter stands out as the world's first of its kind, combining a flexible tip and state-of-the-art contact force technology.

Specifically designed for ablation procedures to address atrial fibrillation (AF), a prevalent abnormal heart rhythm, the TactiFlex™ catheter is showing promise in reducing procedure duration and enhancing safety in comparison to Abbott's previous catheter models.

With over 37 million individuals worldwide living with atrial fibrillation, this condition's prevalence is expected to double by 2050. Each year, an additional five million cases are diagnosed, highlighting the growing healthcare challenge that demands innovative solutions for both patients and healthcare professionals. In regions like Brazil, where atrial fibrillation is a common issue, individuals often grapple with daily challenges such as dizziness, chest pain, and heart palpitations. Left untreated, atrial fibrillation can lead to strokes, emphasizing the critical need for prompt treatment.

What sets the TactiFlex™ apart from other catheters on the market is its inventive design, featuring a laser-cut pattern that flexes upon contact with the heart wall. This design promotes the directed flow of fluid to the targeted tissue and allows for highly precise catheter positioning. As a result, it offers twice the stability within a beating heart, ensuring consistent and accurate delivery of therapy.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024